UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 8 Decent Work and Economic Growth -
SDG 12 Responsible Consumption and Production
Fingerprint
Dive into the research topics where Department of Otorhinolaryngology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
ASO Visual Abstract: Quality of Life in Oropharyngeal Cancer-A Retrospective Analysis of Patient Characteristics and Treatment Modalities
Kim, J. W., Koo, B. S., Kim, H. S., Park, J. H., Park, J. J., Park, J. O., Seok, J. G., Oh, K. H., Woo, S. H., Eun, Y. G., Lee, Y. S., Chung, M. K., Jeong, W. J., Chung, E. J., Ji, Y. B., Yu, S. Y., Lee, S. H., Lee, S. Y. & Cho, K. J., 1 Mar 2026, In: Annals of Surgical Oncology. 33, 3, p. 2505-2506 2 p.Research output: Contribution to journal › Article › peer-review
-
Comparing round window membrane permeability enhancers: An animal study
Han, J. S., Kim, Y. L., Park, K., Lim, J. H., Kim, H. L., Park, S. Y. & Park, S. N., 1 Jan 2026, In: European Journal of Pharmaceutical Sciences. 216, 107256.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparison of turbinate volume reduction surgeries for nasal symptoms and surgery-related adverse effects in patients with chronic rhinitis: a systematic review and network meta-analysis
Kim, D. H., Jang, D. W. & Hwang, S. H., Mar 2026, In: European Archives of Oto-Rhino-Laryngology. 283, 3, p. 1443-1454 12 p.Research output: Contribution to journal › Review article › peer-review
Press/Media
-
Monthly: Vivos Therapeutics (VVOS: $2.85) continues significant downtrend; tumbles 18%
1/04/25
1 item of Media coverage
Press/Media
-
Weekly: Vivos Therapeutics (VVOS: $3.11) plunges 14% on feeble volume; -49c [13.6%]
29/03/25
1 item of Media coverage
Press/Media
-
Weekly: Vivos Therapeutics (VVOS: $3.60) jumps 9% - outperforming 83% of stocks; +30c [9.1%]
22/03/25
1 item of Media coverage
Press/Media